TWiV 905: COVID-19 clinical update #117 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #117, Dr. Griffin discusses duration of virus shedding, association between pre-exposure to steroids and infection outcome, post-infection subtypes, rehabilitation for post-acute infection, Tixagevimab/Cilgavimab for infection prevention, antibody prophylaxis and vaccination in kidney transplant recipients, remdesivir and bebtelovimab fact sheets for providers, the updated guidelines on treatment with Famotidine, Paxlovid rebound symptom characterizations, antigen test positivity duration, viral dynamics of variants and isolation, association of inflammation in CS fluid, and transmission dynamics in Ghana.</p> <p>Subscribe (free): <a title= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784" href= "https://podcasts.apple.com/us/podcast/this-week-in-virology/id1176779065">Apple Podcasts</a>, <a href= "https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3 id="links-for-this-episode"><strong>Links for this episode</strong></h3> <ul> <li>Duration of <a href= "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902872/">virus shedding</a> (NIH)</li> <li><a href= "https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(22)00270-1/fulltext?dgcid=raven_jbs_aip_email"> Association</a> between pre-exposure to steroids and infection outcome (CMI)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2022.05.24.22275398v1">Post-infection</a> subtypes (medRxiv)</li> <li>Rehabilitation for <a href= "https://www.medrxiv.org/content/10.1101/2022.05.24.22275398v1">post-acute infection</a> syndrome (MDPI)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2022.05.28.22275716v1">Tixagevimab/Cilgavimab</a> for infection prevention (medRxiv)</li> <li>Antibody prophylaxis & vaccination in <a href= "